Both in Pharmaceuticals
Zymeworks vs PERRIGO
Over the past year ZYME returned +63.4% and PRGO returned −20.2%; their daily moves had a correlation of 0.13.
ZYME +63.4% PRGO −20.2%Growth of $1, one year, split-adjusted
| Metric | ZYME | PRGO |
|---|---|---|
| Price | $30.86 | $16.38 |
| Market cap | $2.22B | $2.27B |
| Today | +2.42% | +4.30% |
| 1 month | +20.3% | +17.0% |
| 6 months | +11.8% | +33.6% |
| Year to date | +17.2% | +17.6% |
| 1 year | +63.4% | −20.2% |
| Revenue growth (YoY) | −90.6% | −3.2% |
| Gross margin | 100.0% | 30.7% |
| Net margin | −980.8% | 7.3% |
| P/E (TTM) | — | — |
| Price / sales | 59.8× | 0.5× |
| Net cash | $270.7M | -$2.90B |
| Dividend yield | — | 7.08% |
| Volatility (60d) | 47.0% | 40.9% |
| Short % of float | 12.5% | 17.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).